🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Combination therapy in pulmonary arterial hypertension (PAH) has been the s...
Status
Completed
Location
Providence Medical Foundation
Start Date
2019-07-29
Trial ID
NCT03904693
The purpose of this study is to evaluate the bioequivalence of macitentan o...
Status
Completed
Location
SGS Belgium NV
Start Date
2022-06-22
Trial ID
NCT05433675
Treatments Being Tested
The aim of this open-label (OL) trial is to study the long-term use of maci...
Status
Terminated
Location
Massachusetts General Hospital Heart Center
Start Date
2019-04-11
Trial ID
NCT03775421
Treatments Being Tested
The endothelin receptor antagonist macitentan showed significant improvemen...
Status
Terminated
Location
Fukuoka University Nishijin Hospital
Start Date
2019-01-08
Trial ID
NCT03809650
Treatments Being Tested
SYMPHONY is prospective, multi-center, open-label, single-arm, Phase 3b psy...
Status
Completed
Location
Cardiovascular Associates of the Southeast, LLC
Start Date
2013-04-01
Trial ID
NCT01841762
Treatments Being Tested
Prospective, multi-center, open-label, single-arm, Phase 3b psychometric va...
Status
Terminated
Location
Hôpital de Haut Levêque
Start Date
2014-03-01
Trial ID
NCT02081690
Treatments Being Tested
The aim of this Phase 1 trial is to study a potential drug-drug interaction...
Status
Completed
Location
CRS Clinical Research Services Mannheim
Start Date
2017-11-03
Trial ID
NCT03359291
Treatments Being Tested
Prospective, multi-center, open-label, single-arm, Phase 3b extension study...
Status
Completed
Location
Hôpital Louis Pradel
Start Date
2014-06-23
Trial ID
NCT02112487
Treatments Being Tested
The purpose of this study is to demonstrate bioequivalence on the primary p...
Status
Completed
Location
Celerion
Start Date
2020-01-17
Trial ID
NCT04235270
Treatments Being Tested
The main objective of the AC 055 303/SERAPHIN OL study, which will follow t...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2008-10-17
Trial ID
NCT00667823
Treatments Being Tested